Amgen (AMGN) Acquisitions (2011 - 2022)

Amgen (AMGN) has reported Acquisitions for 10 consecutive years, with $3.8 billion the latest figure, recorded in Q4 2022.

• In Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the TTM figure through Dec 2022 stood at $4.7 billion (up 425.14% YoY), while the FY2025 annual figure was $53.0 million, changed N/A from the prior year.
• Acquisitions came in at $3.8 billion for Q4 2022 at Amgen, up from $890.0 million in the prior quarter.
• The five-year high for Acquisitions was $13.4 billion in Q4 2019, with the low at -$197.0 million in Q1 2018.
• Average Acquisitions over 4 years is $2.6 billion, with a median of $177.0 million recorded in 2019.
• Across the five-year window, Acquisitions tumbled 89.47% in 2018 and surged 671900.0% in 2019, its largest moves.
• Year by year, Acquisitions stood at $2.0 million in 2018, then soared by 671900.0% to $13.4 billion in 2019, then plunged by 93.38% to $890.0 million in 2021, then surged by 331.35% to $3.8 billion in 2022.
• According to Business Quant data, Acquisitions over the past three periods registered $3.8 billion, $890.0 million, and $13.0 million for Q4 2022, Q4 2021, and Q3 2021 respectively.